Page last updated: 2024-09-03

5-aza-2'-deoxycytidine-5'-triphosphate and clofarabine

5-aza-2'-deoxycytidine-5'-triphosphate has been researched along with clofarabine in 1 studies

Compound Research Comparison

Studies
(5-aza-2'-deoxycytidine-5'-triphosphate)
Trials
(5-aza-2'-deoxycytidine-5'-triphosphate)
Recent Studies (post-2010)
(5-aza-2'-deoxycytidine-5'-triphosphate)
Studies
(clofarabine)
Trials
(clofarabine)
Recent Studies (post-2010) (clofarabine)
24012424101280

Protein Interaction Comparison

ProteinTaxonomy5-aza-2'-deoxycytidine-5'-triphosphate (IC50)clofarabine (IC50)
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)3.12

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonnac, L; Clouser, CL; Daly, MB; Kim, B; Landman, SR; Mansky, LM; Patterson, SE; Rawson, JM; Reilly, CS; Roth, ME; Xie, J1

Other Studies

1 other study(ies) available for 5-aza-2'-deoxycytidine-5'-triphosphate and clofarabine

ArticleYear
Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase.
    Bioorganic & medicinal chemistry, 2016, 06-01, Volume: 24, Issue:11

    Topics: Anti-HIV Agents; Azacitidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Ribonucleotide Reductases; Structure-Activity Relationship

2016